Power Law company profile

Altus Pharmaceuticals

Biotech & Life Sciences · Independence, United States · Founded 1996 · IPO 2006 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$1.01B

Market cap · Apr/2026

Revenue

$369M

Latest reported FY

Investors

2 investors on Altus Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series B+ 2 investors entered at this stage

Warburg Pincus

U.S. Venture Partners

Global footprint

Where Altus Pharmaceuticals has talent and traffic

Web traffic by country

870 monthly visits
across markets

🇺🇸 United States103.4%

Top 1 markets shown

Patent intelligence

$2M patent portfolio · 2 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$2M

0.20% of market cap · 260.1× smaller than top peer ChemoCentryx ($524M)

2 active patent families

Where Altus Pharmaceuticals innovates CathodeAnodeElectrochemical cellMetalElectrical battery

Below peer median on Legal, Strategic, Market, Economic, Technology

Quality vs same-sector peers

Altus Pharmaceuticals on the five Patsnap quality dimensions

Altus Pharmaceuticals in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Altus Pharmaceuticals concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Altus Pharmaceuticals and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Altus Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo